Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Last updated: August 2022
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 19 items.
Menopur: Out of specification (Assay)
RecallHealth product recall | 2022-08-31
IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure
AlertHealth professional risk communication | 2022-08-29
JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.
RecallHealth product recall | 2022-08-29
NERFASIN 20: Affected lot may contain the presence of particles
RecallHealth product recall | 2022-08-29
Recall of one lot of Jamp-Atorvastatin Calcium as some bottles may be labelled as containing 10 mg tablets, but contain 40 mg tablets
AlertPublic advisory | 2022-08-27
Counterfeit Viagra and Cialis erectile dysfunction drugs seized from Grace Daily Mart in Scarborough, Ontario
AlertPublic advisory | 2022-08-25
PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose
RecallHealth product recall | 2022-08-22
Jamp-Vitamin D: Out of Specification
RecallHealth product recall | 2022-08-22
Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose
AlertPublic advisory | 2022-08-20
Carnivor: Product not manufactured to product specifications and does not contain the required risk information.
RecallHealth product recall | 2022-08-19
Zero Tolerance Plus Sanitizer: Contains undeclared impurity at elevated levels.
RecallHealth product recall | 2022-08-15
Taro-Zoledronic Acid: The affected lots may contain particulate matter
RecallHealth product recall | 2022-08-10
Taro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, recalled because it may contain particulate matter
AlertPublic advisory | 2022-08-09
JAMP-ATORVASTATIN: The affected lot may contain latex.
RecallHealth product recall | 2022-08-08
Jamp-Atorvastatin 40 mg tablets recalled due to risk of latex contamination
AlertPublic advisory | 2022-08-06